Immunoprotein Diagnostic Testing Market Size | Forecast 2031

Segments - Global Immunoprotein Diagnostic Testing Market by Types (C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobin Diagnostic Test, Free Light Chain Diagnostic Test, and Others) Applications (Autoimmune Testing, Allergy Testing, Oncology Testing, Toxicology Testing, and Others), Technology (Radioimmunoassay, Immunoturbidity Assay, Immunoprotein Electrophoresis, Enzyme-linked immunosorbent Assay, and Others), and Regions (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

Immunoprotein Diagnostic Testing Market Outlook 2031:

The global immunoprotein diagnostic testing market size was valued at USD 12.53 Billion in 2022 and is projected to reach USD 22.27 Billion by 2031, expanding at a CAGR of 6.6% during the forecast period 2023 - 2031. Immunoproteins are used as a target for immunological probes or treatments. Immunoprotein diagnostic testing is the process of determining the quantity of immunoproteins in the body in order to analyze diseases associated with specific proteins such as immunoglobulin and pre-albumin.

The COVID-19 pandemic has created a significant issue for all healthcare industry verticals, including the immunoprotein diagnostic testing market. The market is being dealing with emerging obstacles, such as intermittent supply chain events in the manufacturing, production and distribution of diagnostic kits and tests globally.

Furthermore, trade restrictions and a lack of human resources have restricted the delivery of these test kits to customers. However, the increased demand for these products for COVID-19 detection compensates for this negative impact.

Immunoprotein Diagnostic Testing Market Trends, Drivers, Restraints, and Opportunities

Increasing prevalence of infectious and chronic diseases is estimated to drive the market growth.
Rising geriatric population and an increase in demand for early diagnostic services are major factors fueling the growth of the market.
Technical improvements in immunodiagnostic instruments and the introduction of novel automated systems are major factors expected to boost the growth of the immunoprotein diagnostic testing market in the coming years.
Complex regulatory environment for the approval of numerous immunoprotein diagnostic tests can restrain the growth of the market.
Ongoing development in condition-specific assays and tests and the necessity for early diagnosis can provide attractive opportunities for the market growth.

Scope of Immunoprotein Diagnostic Testing Market Report

The report of the global immunoprotein diagnostic testing market includes an assessment of the market, size, share, trends, segments, and regional markets. Overview and dynamics have been included in the report.

Attributes	Details
Report Title	Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016 – 2021
Forecast Period	2023 – 2031
Segmentation	Types (C-reactive Protein Diagnostic Test, Complement System Protein Diagnostic Test, Pre-albumin Diagnostic Test, Haptoglobin Diagnostic Test, Immunoglobin Diagnostic Test, Free Light Chain Diagnostic Test, and Others) Applications (Autoimmune Testing, Allergy Testing, Oncology Testing, Toxicology Testing, and Others), Technology (Radioimmunoassay, Immunoturbidity Assay, Immunoprotein Electrophoresis, Enzyme-linked immunosorbent Assay, and Others)
Regional Scope	Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	F. Hoffmann-La Roche Ag, Abcam PLC, Abbott Laboratories, Diasorin, Enzo Life Sciences, Randox Laboratories, Siemens, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc, Danaher Corporation, Ortho Clinical Diagnostics

Immunoprotein Diagnostic Testing Market Segment Insights

Based on types, the market can be divided into C-reactive protein diagnostic test, complement system protein diagnostic test, pre-albumin diagnostic test, haptoglobin diagnostic test, immunoglobin diagnostic test, free light chain diagnostic test, and others. The immunoglobulin diagnostics test segment is anticipated to hold a large market share during the forecast period.

This is due to the fact that they are widely used and allow healthcare providers to acquire information about a patient's immune system's functioning in autoimmune or infectious disorders. Immunoglobulin testing, however, are ineffective in particular situations, such as during chemotherapy or radiation therapy, and during ongoing blood transfusions or vaccines.

Immunoprotein Diagnostic Testing Market Type

Oncology testing segment to account a significant market share

On the basis of applications, the market can be segregated into autoimmune testing, allergy testing, oncology testing, toxicology testing, and others. The oncology testing segment is anticipated to hold for a significant growth rate during the forecast period. Rising prevalence of cancer is estimated to drive the market growth.

Enzyme-linked immunosorbent assay segment to constitute a major market share

In terms of technology, the market can be segregated into radioimmunoassay, immunoturbidity assay, immunoprotein electrophoresis, enzyme-linked immunosorbent assay, and others. The enzyme-linked immunosorbent assay segment is expected to hold a major market share.

This was attributed to the increased use of immunoassays in cancer, point-of-care IVD testing, infectious disease testing, therapeutic medication level monitoring, and the development of novel biomarkers. The benefits of ELISA include a long shelf life and ease of use, which has led to growing acceptance of these tests in the academic and industrial sectors.

Immunoprotein Diagnostic Testing Market Technology

North America is expected to dominate the market

Based on regions, the market can be divided into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is anticipated to hold over 40% market share during the forecast period due to the increased demand for rapid diagnostic services to detect chronic diseases, the continuous trend of preventative healthcare, and the rise in the number of drug abuse and allergy instances.

Immunoprotein Diagnostic Testing Market Region

Segments

By Types

C-reactive Protein Diagnostic Test
Complement System Protein Diagnostic Test
Pre-albumin Diagnostic Test
Haptoglobin Diagnostic Test
Immunoglobin Diagnostic Test
Free Light Chain Diagnostic Test
Others

By Applications

Autoimmune Testing
Allergy Testing
Oncology Testing
Toxicology Testing
Others

By Technology

Radioimmunoassay
Immunoturbidity Assay
Immunoprotein Electrophoresis
Enzyme-linked immunosorbent assay
Others

By Regions

North America
Europe
Latin America
Asia Pacific
Middle East & Africa

By Key Players

F. Hoffmann-La Roche Ag
Abcam PLC
Abbott Laboratories
Diasorin
Enzo Life Sciences
Randox Laboratories
Siemens
Thermo Fisher Scientific Inc
Bio-Rad Laboratories, Inc
Danaher Corporation
Ortho Clinical Diagnostics

Competitive Landscape

The key players of the immunoprotein diagnostic testing market include F. Hoffmann-La Roche Ag, Abcam PLC, Abbott Laboratories, Diasorin, Enzo Life Sciences, Randox Laboratories, Siemens, Thermo Fisher Scientific Inc, Bio-Rad Laboratories, Inc, Danaher Corporation, Ortho Clinical Diagnostics, among others.

The key players are routing decision growth strategies such as expansion, mergers and acquisitions, partnerships, product launches, and collaborations in order to contribute to the market.

Immunoprotein Diagnostic Testing Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Immunoprotein Diagnostic Testing Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Immunoprotein Diagnostic Testing Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Immunoprotein Diagnostic Testing Market - Supply Chain
  4.5. Global Immunoprotein Diagnostic Testing Market Forecast
     4.5.1. Immunoprotein Diagnostic Testing Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Immunoprotein Diagnostic Testing Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Immunoprotein Diagnostic Testing Market Absolute $ Opportunity
5. Global Immunoprotein Diagnostic Testing Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Types
     5.3.1. C-reactive Protein Diagnostic Test
     5.3.2. Complement System Protein Diagnostic Test
     5.3.3. Pre-albumin Diagnostic Test
     5.3.4. Haptoglobin Diagnostic Test
     5.3.5. Immunoglobin Diagnostic Test
     5.3.6. Free Light Chain Diagnostic Test
     5.3.7. Others
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Immunoprotein Diagnostic Testing Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Applications
     6.3.1. Autoimmune Testing
     6.3.2. Allergy Testing
     6.3.3. Oncology Testing
     6.3.4. Toxicology Testing
     6.3.5. Others
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Immunoprotein Diagnostic Testing Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Immunoprotein Diagnostic Testing Demand Share Forecast, 2019-2026
8. North America Immunoprotein Diagnostic Testing Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Types
     8.4.1. C-reactive Protein Diagnostic Test
     8.4.2. Complement System Protein Diagnostic Test
     8.4.3. Pre-albumin Diagnostic Test
     8.4.4. Haptoglobin Diagnostic Test
     8.4.5. Immunoglobin Diagnostic Test
     8.4.6. Free Light Chain Diagnostic Test
     8.4.7. Others
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Applications
     8.7.1. Autoimmune Testing
     8.7.2. Allergy Testing
     8.7.3. Oncology Testing
     8.7.4. Toxicology Testing
     8.7.5. Others
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Immunoprotein Diagnostic Testing Demand Share Forecast, 2019-2026
9. Latin America Immunoprotein Diagnostic Testing Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Types
     9.4.1. C-reactive Protein Diagnostic Test
     9.4.2. Complement System Protein Diagnostic Test
     9.4.3. Pre-albumin Diagnostic Test
     9.4.4. Haptoglobin Diagnostic Test
     9.4.5. Immunoglobin Diagnostic Test
     9.4.6. Free Light Chain Diagnostic Test
     9.4.7. Others
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Applications
     9.7.1. Autoimmune Testing
     9.7.2. Allergy Testing
     9.7.3. Oncology Testing
     9.7.4. Toxicology Testing
     9.7.5. Others
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Immunoprotein Diagnostic Testing Demand Share Forecast, 2019-2026
10. Europe Immunoprotein Diagnostic Testing Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Types
     10.4.1. C-reactive Protein Diagnostic Test
     10.4.2. Complement System Protein Diagnostic Test
     10.4.3. Pre-albumin Diagnostic Test
     10.4.4. Haptoglobin Diagnostic Test
     10.4.5. Immunoglobin Diagnostic Test
     10.4.6. Free Light Chain Diagnostic Test
     10.4.7. Others
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Applications
     10.7.1. Autoimmune Testing
     10.7.2. Allergy Testing
     10.7.3. Oncology Testing
     10.7.4. Toxicology Testing
     10.7.5. Others
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Immunoprotein Diagnostic Testing Demand Share Forecast, 2019-2026
11. Asia Pacific Immunoprotein Diagnostic Testing Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Types
     11.4.1. C-reactive Protein Diagnostic Test
     11.4.2. Complement System Protein Diagnostic Test
     11.4.3. Pre-albumin Diagnostic Test
     11.4.4. Haptoglobin Diagnostic Test
     11.4.5. Immunoglobin Diagnostic Test
     11.4.6. Free Light Chain Diagnostic Test
     11.4.7. Others
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Applications
     11.7.1. Autoimmune Testing
     11.7.2. Allergy Testing
     11.7.3. Oncology Testing
     11.7.4. Toxicology Testing
     11.7.5. Others
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Immunoprotein Diagnostic Testing Demand Share Forecast, 2019-2026
12. Middle East & Africa Immunoprotein Diagnostic Testing Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Types
     12.4.1. C-reactive Protein Diagnostic Test
     12.4.2. Complement System Protein Diagnostic Test
     12.4.3. Pre-albumin Diagnostic Test
     12.4.4. Haptoglobin Diagnostic Test
     12.4.5. Immunoglobin Diagnostic Test
     12.4.6. Free Light Chain Diagnostic Test
     12.4.7. Others
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Immunoprotein Diagnostic Testing Market Size and Volume Forecast by Applications
     12.7.1. Autoimmune Testing
     12.7.2. Allergy Testing
     12.7.3. Oncology Testing
     12.7.4. Toxicology Testing
     12.7.5. Others
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Immunoprotein Diagnostic Testing Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Immunoprotein Diagnostic Testing Market: Market Share Analysis
  13.2. Immunoprotein Diagnostic Testing Distributors and Customers
  13.3. Immunoprotein Diagnostic Testing Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. F. Hoffmann-La Roche Ag
     13.4.2. Abcam PLC
     13.4.3. Abbott Laboratories
     13.4.4. Diasorin
     13.4.5. Enzo Life Sciences
     13.4.6. Randox Laboratories
     13.4.7. Siemens
     13.4.8. Thermo Fisher Scientific